251 related articles for article (PubMed ID: 22884656)
1. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844
[TBL] [Abstract][Full Text] [Related]
3. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
[TBL] [Abstract][Full Text] [Related]
5. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.
Li XY; Lin YC; Huang WL; Hong CQ; Chen JY; You YJ; Li WB
Med Oncol; 2012 Jun; 29(2):714-20. PubMed ID: 21431960
[TBL] [Abstract][Full Text] [Related]
7. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic Acid Inhibits the Motility of Cancer Stem-like Cells from the Human Breast Cancer Cell Line MDA-MB 231.
Bühler H; Hoberg C; Fakhrian K; Adamietz IA
In Vivo; 2016 11-12; 30(6):761-768. PubMed ID: 27815459
[TBL] [Abstract][Full Text] [Related]
9. EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.
Ellina MI; Bouris P; Aletras AJ; Theocharis AD; Kletsas D; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2651-61. PubMed ID: 24792576
[TBL] [Abstract][Full Text] [Related]
10. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
11. Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells.
Wu L; Zhu L; Shi WH; Zhang J; Ma D; Yu B
Eur J Pharmacol; 2009 Jan; 602(1):124-31. PubMed ID: 19000670
[TBL] [Abstract][Full Text] [Related]
12. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
13. Modeling of hypo/hyperglycemia and their impact on breast cancer progression related molecules.
Adham SA; Al Rawahi H; Habib S; Al Moundhri MS; Viloria-Petit A; Coomber BL
PLoS One; 2014; 9(11):e113103. PubMed ID: 25401697
[TBL] [Abstract][Full Text] [Related]
14. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.
Vijaya Kumar A; Salem Gassar E; Spillmann D; Stock C; Sen YP; Zhang T; Van Kuppevelt TH; Hülsewig C; Koszlowski EO; Pavao MS; Ibrahim SA; Poeter M; Rescher U; Kiesel L; Koduru S; Yip GW; Götte M
Int J Cancer; 2014 Dec; 135(11):2579-92. PubMed ID: 24752740
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid-induced cytotoxicity through endoplasmic reticulum stress triggered REDD1-mTOR pathway in breast cancer cells.
Lan YC; Chang CL; Sung MT; Yin PH; Hsu CC; Wang KC; Lee HC; Tseng LM; Chi CW
Anticancer Res; 2013 Sep; 33(9):3807-14. PubMed ID: 24023313
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
Tamura T; Shomori K; Nakabayashi M; Fujii N; Ryoke K; Ito H
Oncol Rep; 2011 Apr; 25(4):1139-43. PubMed ID: 21249320
[TBL] [Abstract][Full Text] [Related]
17. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size.
Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK
FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
Boissier S; Ferreras M; Peyruchaud O; Magnetto S; Ebetino FH; Colombel M; Delmas P; Delaissé JM; Clézardin P
Cancer Res; 2000 Jun; 60(11):2949-54. PubMed ID: 10850442
[TBL] [Abstract][Full Text] [Related]
19. Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
Fanale D; Amodeo V; Bazan V; Insalaco L; Incorvaia L; Barraco N; Castiglia M; Rizzo S; Santini D; Giordano A; Castorina S; Russo A
Oncotarget; 2016 May; 7(20):29321-32. PubMed ID: 27081088
[TBL] [Abstract][Full Text] [Related]
20. Low zoledronate concentrations stimulate human keratinocyte proliferation.
Migliario M; Rizzi M; Rocchetti V; Pittarella P; Renò F
Pharmacology; 2013; 91(3-4):201-6. PubMed ID: 23428615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
